The immunoexpression of bcl-2 and p53 in Kaposi's sarcoma

Histopathology

Volumn 29, Issue 2, 1996, Pages 159-163

  Dada, M A ^a   Chetty, R ^c   Biddolph, S C ^b   Schneider, J W ^d   Gatter, K C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NATAL   (South Africa)

^d STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

bcl 2; Kaposis sarcoma; MIB 1; p53

Indexed keywords

PROTEIN BCL 2; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPOSI SARCOMA; MALE; ONCOGENE; PRIORITY JOURNAL;

EID: 0029788246     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1996.d01-493.x     Document Type: Article

References (17)

1. King KL, Squier MKT, Sellins KS. Cell death comes to life in purgatory: a keystone meeting on apoptosis. Trends Cell. Biol. 1995; 5; 287-289.
2. Chetty R, Kaklamanis L, Biddolph SC et al. bcl-2 protein is upregulated in post-transplant lymphoproliferative disorders. J. Pathol. (in press).
3. Chetty R, Biddolph SC, Kaklamanis I, et al. Reed-Sternberg-like cells in post-transplant lymphoproliferative disorders: an immunohistochemical analysis. Hum. Pathol. (in press).
4. Finlay CA, Hinds PW, Levine AJ. The p53 protooncogene can act as a suppressor of transformation. Cell 1989; 57; 1083-1093.
5. Gallo RC. Human retroviruses in the second decade: A personal perspective. Nature Med. 1995; 1; 753-759.
6. Lunardi-Iskandar Y, Bryant JL, Zeman RA et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 1995; 375; 64-68.
7. Norton AJ, Jordan S, Yeomans P. Brief, high temperature denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J. Pathol. 1994; 173; 371-379.
8. Pezzella F, Gatter KC. What is the value of bcl-2 protein detection for histopathologists? Histopathology 1995; 26; 89-93.
9. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992; 359; 554-556.
10. Reed JC, Haldar S, Croce CM, Cuddy MP. Complementation by BCL-2 and C-HA-RAS oncogenes in malignant transformation of rat embryo fibroblasts. Mol. Cell. Biol. 1990; 10; 4370-4374.
11. Mason DY, Gatter KC. Immunohistochemistry in histological diagnosis. In Anthony PP, MacSween RNM eds. Recent Advances in Histopathology 16. Edinburgh: Churchill Livingstone, 1994; 263-292.
12. Pezzella F, Morrison H, Jones M et al. Immunohistochemical detection of p53 and bcl-2 protein in non-Hodgkin's lymphoma. Histopathology 1993; 22; 39-44.
13. Nunez G, Clarke MF. The bcl-2 family of proteins: regulators of cell death and survival. Trends Cell. Biol. 1994; 4; 399-403.
14. Piris MA, Pezzella F, Martinez-Montero JC et al. p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time. Br. J. Cancer 1994; 69; 337-341.
15. Dei Tos AP, Doglioni C, Laurino L, Barbareschi M, Fletchcr CD. p53 protein expression in non-neoplastic lesions and benign and malignant neoplasma of soft tissue. Histopathology 1993; 22; 45-50.
16. Keshgegian AA, Cnaan A. Mitiotic figure count. S-phase fraction, proliferating cell nuclear antigen, Ki-67, and MIB-1. Am. J. Clin. Pathol. 1995; 104; 42-49.
17. Henderson S, Rowe M, Gregory C et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein I protects infected B cells from programmed cell death. Cell 1991; 65; 1107-1115.